Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Intercept Pharmaceuticals, Inc.

NASDAQ: ICPTHealthcare / Biotechnology / USA
91.83-7.20-7.27%Vol 4 254 5821Y Perf 54.07%
Feb 21st, 2019 16:00
BID91.40 ASK91.98
Open97.47 Previous Close99.03
Pre-Market98.00 After-Trading92.87
 -1.03 -1.04%  1.04 1.13%
Target Price
147.09 
Analyst Rating
Moderate Buy 1.67
Potencial %
60.18 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/-74 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-78 
Growth Ranking
★+     39.68
Insiders Shares Cnt. % 3/6/12M
-100/-100/-67 
Income Ranking
 —    -
Market Cap (mil)2 723 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
44.64 
Earnings Date
27th Feb 2019

Today's Price Range

90.5598.64

 

52wk Range

58.03133.74

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-17.22%
3 Months
-16.31%
6 Months
-15.26%
1 Year
54.07%
3 Years
-24.58%
5 Years
-75.19%

Quotes

Name / TickerPriceChg.Chg.%
ICPT91.83-7.2000-7.27
AAPL171.06-0.9700-0.56
GOOG1 096.97-16.8300-1.51
MSFT109.412.26002.11
XOM77.82-0.7100-0.90
WFC49.56-0.2500-0.50
JNJ135.42-0.9300-0.68
FB160.04-2.5200-1.55
GE10.03-0.0700-0.69
JPM105.47-0.2200-0.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
5.80
Current Ratio
6.00
Long Term Debt to Total Capital
0.79
Total Debt to Equity
3.83
Interest Coverage
-10.00
Leverage Ratio 8.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
98.60
EBIT Margin
-184.10
EBITDA Margin
-181.10
Pre-tax Profit Margin
-5 320.50
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
34.37
PS Ratios
26.06
Price to Cash Flow
-
Price to Free Cash Flow
-17.50
Cash Flow Per Share
-9.67
Price to Tangible Book
34.37
Book Value per Share
3.23
Enterprise Value (in ths.)
3 171 270
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-104.22
ROE last 12 Months
-322.30
Return on Assets (5Y Avg)
-49.53
ROA last 12 Months
-59.82
Return on Capital (5Y Avg)
-82.76
ROC last 12 Months
-65.24
Return on invested Capital Q
-11.67
Return on invested Capital Y
-64.39
Assets Turnover
0.20
Receivables Turnover
6.30
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
126 524
Revenue per Share
4.27
Revenue Growth 3 Years
259.05
Revenue Growth 5 Years
169.97
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-2.65-2.1817.74
Q02 2018-2.83-2.588.83
Q01 2018-3.41-3.225.57
Q04 2017-3.57-4.43-24.09
Q03 2017-3.55-2.8918.59
Q02 2017-3.62-3.464.42
Q01 2017-4.27-3.6115.46
Q04 2016-3.58-4.84-35.20
Earnings Per EndEstimateRevision %Trend
12/2018 QR-2.421.22Positive
12/2018 FY-10.320.29Positive
3/2019 QR-2.33-2.64Negative
12/2019 FY-7.89-2.60Negative
Next Report Date27th Feb 2019
Estimated EPS Next Report-2.42
Estimates Count10
EPS Growth Next 5 Years %-
Volume Overview
Volume4 254 582
Shares Outstanding (in ths.)29 654
Trades Count21 044
Dollar Volume335 809 960
Avg. Volume1 008 094
Avg. Weekly Volume3 486 378
Avg. Monthly Volume1 385 370
Avg. Quarterly Volume761 550

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

47%53%

Bearish Bullish

71%29%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
10 (66.67 %)
8 (61.54 %)
6 (50.00 %)
Moderate Buy
1 (6.67 %)
1 (7.69 %)
1 (8.33 %)
Hold
3 (20.00 %)
3 (23.08 %)
4 (33.33 %)
Moderate Sell
1 (6.67 %)
1 (7.69 %)
1 (8.33 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.67
Moderate Buy
1.77
Moderate Buy
2.00

There are no comments yet.

News